StockNews.com initiated coverage on shares of OncoCyte (NYSE:OCX – Get Rating) in a report published on Thursday. The brokerage issued a sell rating on the stock.
OncoCyte Stock Down 2.5 %
OncoCyte stock opened at $0.21 on Thursday. OncoCyte has a 52-week low of $0.20 and a 52-week high of $1.35.
Want More Great Investing Ideas?
- Get a free copy of the StockNews.com research report on OncoCyte (OCX)
- Ralph Lauren’s Styled Dividend Is Still In Season
- Dollar Tree Falls As Theft Cuts Into Bottom Line
- Best Buy’s Comeback Is Still At Play, Earnings Call For Patience
- e.l.f. Beauty Has Giant Quarter, Shares Hit New High
- If You Can Only Pick One Stock For The Rest Of 2023, Pick Nvidia
Receive News & Ratings for OncoCyte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OncoCyte and related companies with MarketBeat.com's FREE daily email newsletter.